|
KIN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.932000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.762000E-01 |
| Normal-vs-Stage2 |
4.565600E-01 |
| Normal-vs-Stage3 |
4.650400E-01 |
| Normal-vs-Stage4 |
4.457000E-01 |
| Stage1-vs-Stage2 |
8.481000E-01 |
| Stage1-vs-Stage3 |
1.753950E-01 |
| Stage1-vs-Stage4 |
2.067000E-01 |
| Stage2-vs-Stage3 |
1.844370E-01 |
| Stage2-vs-Stage4 |
2.664400E-01 |
| Stage3-vs-Stage4 |
7.508400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.011600E-01 |
| Normal-vs-AfricanAmerican |
6.561400E-01 |
| Normal-vs-Asian |
1.534640E-01 |
| Caucasian-vs-AfricanAmerican |
3.252600E-01 |
| Caucasian-vs-Asian |
1.054220E-02 |
| AfricanAmerican-vs-Asian |
8.765600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.558200E-01 |
| Normal-vs-Female |
1.006370E-01 |
| Male-vs-Female |
6.820800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.724800E-01 |
| Normal-vs-Extreme_Weight |
5.040800E-01 |
| Normal-vs-Obese |
8.170600E-01 |
| Normal-vs-Extreme_Obese |
1.800150E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.196400E-01 |
| Normal_Weight-vs-Obese |
1.571580E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.855400E-01 |
| Extreme_Weight-vs-Obese |
2.717400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.677000E-01 |
| Obese-vs-Extreme_Obese |
1.777960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.607710E-02 |
| Normal-vs-Age(41-60Yrs) |
4.029000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.952600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.155700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.471600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.8714999999987E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.404100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.067890E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.811900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.629200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.299200E-01 |
| Normal-VS-Type2 PRCC |
4.488000E-02 |
| Normal-VS-KIRP CIMP |
1.608920E-04 |
| Normal-VS-Unclassified PRCC |
9.086200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.302100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.367600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.717000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.25730000000157E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
4.898300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.935800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.141620E-01 |
| Normal-vs-N1 |
3.512100E-02 |
| Normal-vs-N2 |
7.310000E-01 |
| N0-vs-N1 |
4.521200E-03 |
| N0-vs-N2 |
7.617600E-01 |
| N1-vs-N2 |
2.814400E-01 |
|
|
